- Home
- NEGG vs GNFT Comparison
NEGG vs GNFT Comparison
Compare NEGG & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- GNFT
- Stock Information
- Founded
- NEGG 2001
- GNFT 1999
- Country
- NEGG United States
- GNFT France
- Employees
- NEGG N/A
- GNFT N/A
- Industry
- NEGG Other Specialty Stores
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NEGG Consumer Discretionary
- GNFT Health Care
- Exchange
- NEGG Nasdaq
- GNFT Nasdaq
- Market Cap
- NEGG 293.6M
- GNFT 296.4M
- IPO Year
- NEGG 2010
- GNFT 2019
- Fundamental
- Price
- NEGG $0.57
- GNFT $4.05
- Analyst Decision
- NEGG
- GNFT Strong Buy
- Analyst Count
- NEGG 0
- GNFT 1
- Target Price
- NEGG N/A
- GNFT $13.00
- AVG Volume (30 Days)
- NEGG 630.5K
- GNFT 7.6K
- Earning Date
- NEGG 12-10-2024
- GNFT 09-19-2024
- Dividend Yield
- NEGG N/A
- GNFT N/A
- EPS Growth
- NEGG N/A
- GNFT N/A
- EPS
- NEGG N/A
- GNFT 0.47
- Revenue
- NEGG $1,391,833,000.00
- GNFT $86,225,222.00
- Revenue This Year
- NEGG $6.01
- GNFT $155.44
- Revenue Next Year
- NEGG N/A
- GNFT N/A
- P/E Ratio
- NEGG N/A
- GNFT $8.62
- Revenue Growth
- NEGG N/A
- GNFT 175.45
- 52 Week Low
- NEGG $0.56
- GNFT $3.12
- 52 Week High
- NEGG $2.15
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- NEGG 39.46
- GNFT 25.70
- Support Level
- NEGG $0.62
- GNFT $4.17
- Resistance Level
- NEGG $0.64
- GNFT $4.41
- Average True Range (ATR)
- NEGG 0.05
- GNFT 0.11
- MACD
- NEGG -0.00
- GNFT -0.05
- Stochastic Oscillator
- NEGG 8.06
- GNFT 4.13
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.